David Berk
About David Berk
David Berk is the Manager of US Medical Affairs Operations Hematology at Bristol-Myers Squibb - Celgene in Summit, New Jersey, with extensive experience in financial analysis and contract management within the pharmaceutical and healthcare industries.
Current Title and Role
David Berk holds the position of Manager, US Medical Affairs Operations Hematology at Bristol-Myers Squibb – Celgene. Based in Summit, New Jersey, David's responsibilities include overseeing medical affairs operations specifically related to hematology.
Work Experience at Bristol-Myers Squibb - Celgene
Since November 2015, David Berk has been an integral part of Bristol-Myers Squibb - Celgene. His role as Manager in US Medical Affairs Operations Hematology involves coordination of medical affairs, ensuring effective communication, and managing operations to support hematology projects and initiatives.
Previous Positions and Experience
Before joining Bristol-Myers Squibb, David Berk accumulated extensive experience across various companies. From 2010 to 2015, he served as Contract Manager at PRA Health Sciences. Prior roles include Grants Specialist at Schering-Plough Pharmaceuticals (2009-2010), Sr. Clinical Trial Associate at Merck (2007-2008), Sr. Financial Analyst at Pharmacopeia (2007), Contract & Compliance Analyst at Cordis (2004-2006), and Financial Analyst positions at RCN (1999-2001) and Beneficial Corporation (1996-1999).
Educational Background
David Berk earned a BS in Management Science from Rider University, where he studied from 1988 to 1994. He also attended The Peddie School from 1985 to 1988. His academic background provided a solid foundation for his career in financial analysis and management.
Expertise in Financial Analysis
David Berk has specialized expertise in financial analysis within the pharmaceutical, healthcare, insurance, and hospital industries. His skills encompass financial reporting, budget and forecasting, as well as contract negotiations. David aims to continue growing in the field of financial reporting.